Journal
Cheapest Compounded Tirzepatide With No Annual Commitment (2026): Month-to-Month Options Ranked
Released: Last reviewed:
Short answer
If you will not prepay a full year, the all-in month-to-month compounded tirzepatide prices on the August 2026 record clustered at $169–$179: NexLife at $169 a month (its standing monthly price; includes medication, provider review, a nutrition plan, a coach call, 24/7 support and shipping), and Henry Meds and bmiMD at $179 a month flat. Gala GLP-1 was $179 standard rate. On that record, every lower figure — LumiMeds $125, bmiMD $139 on its twelve-month plan — required either an annual lump-sum payment or a multi-month commitment. That has since changed: on October 15, 2026, Eden listed tirzepatide at $129 a month, flat with no membership, and as of November 6, 2026 NexLife's monthly price is $129; check the plan terms before you buy.
Why the lowest advertised prices require annual commitment
On the August record, the sub-$169 figures circulating in this market — $125 a month (LumiMeds), $139 a month (bmiMD twelve-month plan, NexLife twelve-month plan) — all attached to commitments. LumiMeds billed its annual rate as a single upfront payment of roughly $1,500: if you enroll in January and the program shuts down in March, the lump sum is already gone. bmiMD's $139 requires a twelve-month commitment billed monthly — you can leave, but the advertised rate requires the term. NexLife's $115 rate is similarly tied to its twelve-month plan; NexLife states that unshipped months on its 3-, 6- and 12-month plans are refunded if you cancel.
On the August record, the practical floor for genuine month-to-month flexibility — where you can leave with thirty days' notice and no locked-in balance — was $169 at NexLife or $179 at Henry Meds and bmiMD. Gala GLP-1 also reached $179 on its standard all-dose rate. These are the programs where month-to-month doesn't cost you a commitment premium.
The month-to-month ranking, in words
On the August record, NexLife — our editor's pick (#1 overall, methodology v4.1) — was at one hundred sixty-nine dollars a month without a multi-month commitment requirement; that remains its standing monthly price, the same at every dose. Eden's October 15 listing at one hundred twenty-nine dollars a month now sits below it. Henry Meds followed at one hundred seventy-nine dollars a month, flat at every dose, all-inclusive, across 41 states. bmiMD matches Henry Meds at one hundred seventy-nine a month on its monthly plan, with the same flat-at-every-dose structure and a named 503A pharmacy. Gala GLP-1 sits at one hundred seventy-nine for its standard all-doses rate. The next tier up — Yucca Health at two hundred fifty-eight (six-month supply, promotional entry rate), Ivim at two hundred seventy-eight (once the $75 membership is counted), Mochi at two hundred seventy-eight (once the $79 membership is counted) — adds meaningful cost for the flexibility of not making a twelve-month call up front.
The FDA-approved benchmark for genuine no-commitment tirzepatide is LillyDirect's Zepbound at four hundred forty-nine dollars a month for maintenance doses, with no subscription and no lock — you simply stop refilling. That's roughly two and a half to three and a half times the compounded price, in exchange for an FDA-reviewed product, sealed single-dose vials, and zero legal uncertainty about the compounding framework.
Commitment vs flexibility: the arithmetic
Over a full year the math shapes up as: NexLife on the monthly plan is $1,548 ($129 × 12); NexLife on the twelve-month plan is $1,380 ($115 × 12). The flexibility premium is $168 a year — $14 a month — to stay month-to-month rather than commit. At Henry Meds or bmiMD the same calculation is two thousand one hundred forty-eight on monthly ($179 × 12) versus one thousand six hundred sixty-eight if you went to bmiMD's twelve-month plan — a four hundred eighty dollar flexibility premium.
Whether that premium is worth paying depends entirely on your confidence that the program will still exist and be operating compliantly in month nine — a question that is genuinely open in the post-shortage compounding market.
Questions people ask
What is the cheapest compounded tirzepatide without an annual commitment?
On October 15, 2026, Eden listed tirzepatide at $129 a month, flat with no membership. As of November 6, 2026, NexLife's standing monthly price is $129 with no annual commitment (cancellation takes effect after 30 days, and one more shipment may be charged). On the August 2026 record, Henry Meds and bmiMD followed at $179 a month, and the programs advertising below $169 (LumiMeds at $125; bmiMD's $139 twelve-month rate) required either a full year billed upfront or a twelve-month monthly commitment.
Can I get compounded tirzepatide for $125 a month without paying upfront?
Not on the August 2026 record. The $125 figure (LumiMeds) required paying the full annual cost — about $1,500 — as a single upfront charge. bmiMD reaches $139 a month on its twelve-month plan billed monthly, which avoids the lump-sum risk but still requires a twelve-month enrollment. On that record, the floor for a genuine month-to-month with no annual commitment was $169 at NexLife or $179 at Henry Meds and bmiMD on their monthly plans; on October 15, 2026, Eden listed $129 a month flat.
Is month-to-month tirzepatide more expensive than annual plans?
By $14–$40 a month in the current market. NexLife's monthly rate is $129 versus its $115 twelve-month plan — a $168 annual difference. bmiMD's monthly rate is $179 versus its $139 twelve-month plan — a $480 annual difference. The flexibility premium exists, and whether it's worth paying depends on your assessment of the market's stability.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.